What are the indications, contraindications, side effects, and dosage of nimesulide tablets?

Nimesulide: Indications, Contraindications, Side Effects, and Dosage

Direct Answer

Nimesulide 100 mg twice daily is the optimal dose for treating acute pain and inflammation, including osteoarthritis, low back pain, gouty arthritis, post-operative pain, and dysmenorrhea, but it should be avoided in patients with liver disease, renal impairment, or history of GI bleeding. 1, 2

Indications

Nimesulide is indicated for temporary relief of:

• Acute pain conditions: headache, muscular aches, backache, toothache 1
• Inflammatory conditions: osteoarthritis, acute low back pain, gouty arthritis 3, 4, 5
• Menstrual pain: premenstrual or menstrual cramps 1
• Post-operative pain: following general surgery and oral surgery 5
• Minor arthritis pain 1
• Fever reduction 1
• Pain from common cold 1

The drug demonstrates rapid onset of analgesia within 1.5 hours and maintains effect throughout a 12-hour period 2. Clinical studies show significant pain reduction in acute low back pain by day 5 of treatment 3.

Dosage

Adults and Children ≥12 Years

Standard dose: 100 mg twice daily (every 12 hours) 2

• Alternative dosing from FDA labeling: 2 tablets every 4-6 hours while symptoms last 1
• Maximum: Not more than 12 tablets in 24 hours 1
• Treatment duration: Typically 7-14 days for acute conditions 4, 6

Children 6-11 Years

• 1 tablet every 4-6 hours while symptoms last 1
• Maximum: Not more than 5 tablets in 24 hours 1

Children <6 Years

• Do not use 1

Clinical note: The 100 mg twice daily regimen demonstrated the optimal efficacy/safety ratio in a 392-patient study, showing better tolerability than the 200 mg twice daily dose while maintaining equivalent analgesic efficacy 2.

Contraindications

Absolute Contraindications

• Active liver disease or cirrhosis - nimesulide carries hepatotoxicity risk 7, 1
• Severe renal impairment - NSAIDs can worsen renal function 7
• History of NSAID-associated upper GI bleeding 7
• Congestive heart failure 7
• Active peptic ulcer disease
• Children under 6 years 1

Relative Contraindications (Use with Extreme Caution)

• Concurrent anticoagulant therapy - increases GI bleeding risk 3-6 fold 7
• Platelet defects or thrombocytopenia 7
• Asthma with nasal polyps or recurrent sinusitis - risk of aspirin-exacerbated respiratory disease 7
• Hypertension - NSAIDs can increase blood pressure by mean of 5 mm Hg 7
• Concurrent use with ACE inhibitors or beta blockers - additive renal impairment risk 7
• Alcohol consumption (≥3 drinks daily) - severe liver damage risk when combined with acetaminophen formulations 1

Side Effects

Common (10-20% prevalence)

• Dyspepsia and abdominal pain 7
• GI discomfort 7

In clinical studies, only 1 of 54 patients showed elevated hepatic transaminases, and 2 patients experienced dyspepsia without endoscopic GI changes 3.

Serious but Less Common

• GI bleeding: Age-dependent risk - 1 in 2,100 for adults <45 years vs. 1 in 110 for adults >75 years 7
• Hepatotoxicity: Severe liver damage possible, especially with overdose or alcohol use 1
• Cardiovascular events: Worsening hypertension, myocardial infarction (excess of 3.5 cardiac events per 1,000 persons with COX-2 inhibitors) 7
• Renal impairment: 2% of NSAID users discontinue due to renal complications 7
• Increased bleeding risk: INR increases up to 15% when combined with anticoagulants 7

Endoscopic Findings

A 7-day study showed minimal gastric injury: 1 patient on 100 mg developed superficial ulcerations, and 1 patient on 200 mg developed corpus mucosa erosions 6. This suggests relatively favorable GI tolerability compared to non-selective NSAIDs.

Critical Safety Considerations

Hepatic Monitoring

Avoid nimesulide in patients with baseline liver disease - the drug has documented hepatotoxicity risk, though primary hepatic complications are usually reversible 7. Maximum daily dose limits must be strictly observed 1.

Cardiovascular Risk Stratification

Patients at elevated cardiovascular risk should avoid COX-2 selective inhibitors entirely 7. Blood pressure monitoring is essential in hypertensive patients 7.

Drug Interactions Requiring Dose Adjustment

• With anticoagulants: Expect INR increase; consider PPI co-therapy 7
• With other NSAIDs or acetaminophen: Risk of exceeding maximum safe doses 1

GI Protection Strategy

For patients requiring nimesulide despite GI risk factors:

• Combine with PPI or misoprostol 7
• Consider celecoxib alternative if cardiovascular risk is low 7
• Avoid in patients with prior NSAID-associated bleeding (5% recurrence risk in first 6 months) 7

Common pitfall: Nimesulide formulations may contain acetaminophen - verify total daily acetaminophen intake does not exceed 4,000 mg to prevent hepatotoxicity 1.